Dipole Density Right Atrial Mapping and Assessment of Therapy In Cavotricuspid Isthmus Flutter
- Conditions
- Atrial Flutter
- Interventions
- Device: Acutus Medical System Mapping
- Registration Number
- NCT01872052
- Lead Sponsor
- Acutus Medical
- Brief Summary
Study to determine the feasibility of the Acutus Medical System in obtaining data to create Dipole Density Maps of electrical activation in the right atrium in patients with typical atrial flutter.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 9
- Age 18-75 years
- One documented occurrence of typical AFL within the past 6 months
- Be able and willing to sign informed consent
- Contraindication to a non-emergent interventional EP procedure
- Require treatment in or access to left atrium
- Had a myocardial infarction within the prior two months
- Had cardiac surgery within the prior three months
- Intracardiac thrombus
- Permanent pacemaker/ICD leads in/through right atrium
- Clinically significant tricuspid valve regurgitation or stenosis
- Cerebral ischemic event (including TIA) in the prior six months
- Pregnant
- Currently enrolled in any other clinical investigation
- Any other significant uncontrolled or unstable medical condition
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Acutus Medical System Acutus Medical System Mapping -
- Primary Outcome Measures
Name Time Method The number of patients in which offline construction of pre- and post-treatment activation maps can be completed 3 months post-procedure Proprietary software algorithms will be used generate electrical activation maps based dipole density data acquired by the Acutus Medical Catheter during the procedures. These activation maps will then be applied to a 3D model of the endocardial surface to create a 3D activation map.
The number of patients that experience a device-related adverse events as a measure of safety and tolerability 7 days post-procedure
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
AZ Sint-Jan
🇧🇪Brugge, Belgium